Skip to content
10-Q

Quarterly Report

Turnstone Biologics Corp.

0000950170-24-097065

← back to feed
Filed
Aug 14, 2024 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2024 · Aug 12, 2024 23.13M sh
Short Term Investments Q2 2024 · Jun 30, 2024 $45M
Short Term Investments Q2 2024 · Dec 31, 2023 $76.98M
Cash And Equivalents Q2 2024 · Jun 30, 2024 $17.4M
Cash And Equivalents Q2 2024 · Dec 31, 2023 $17.8M
Current Liabilities Q2 2024 · Jun 30, 2024 $15.63M
Current Liabilities Q2 2024 · Dec 31, 2023 $11.97M
Total Liabilities Q2 2024 · Jun 30, 2024 $17.14M
Total Liabilities Q2 2024 · Dec 31, 2023 $14.15M
Current Assets Q2 2024 · Jun 30, 2024 $68.4M
Current Assets Q2 2024 · Dec 31, 2023 $102.55M
Total Assets Q2 2024 · Jun 30, 2024 $76.88M
Total Assets Q2 2024 · Dec 31, 2023 $112.82M
Rd Expense Q2 2024 · Jun 30, 2024 $17.73M
Rd Expense Q2 2024 · Jun 30, 2024 $33.52M
Rd Expense Q2 2024 · Jun 30, 2023 $17.19M
Rd Expense Q2 2024 · Jun 30, 2023 $32.86M
Shares Diluted Q2 2024 · Jun 30, 2023 2.85M sh
Shares Diluted Q2 2024 · Jun 30, 2023 2.82M sh
Capex Q2 2024 · Jun 30, 2023 $990K
Operating Cash Flow Q2 2024 · Jun 30, 2023 −$31.86M
Stockholders Equity Q2 2024 · Jun 30, 2023 −$120.61M
Stockholders Equity Q2 2024 · Mar 31, 2023 −$100.22M
Stockholders Equity Q2 2024 · Dec 31, 2022 −$101.47M
Eps Diluted Q2 2024 · Jun 30, 2023 −$7.56
Eps Diluted Q2 2024 · Jun 30, 2023 −$7.62
Eps Basic Q2 2024 · Jun 30, 2023 −$7.56
Eps Basic Q2 2024 · Jun 30, 2023 −$7.62
Sga Expense Q2 2024 · Jun 30, 2023 $4.66M
Sga Expense Q2 2024 · Jun 30, 2023 $8.69M
Net Income Q2 2024 · Jun 30, 2023 −$21.5M
Net Income Q2 2024 · Jun 30, 2023 −$21.43M
Net Income Q2 2024 · Mar 31, 2023 $68K
Operating Income Q2 2024 · Jun 30, 2023 −$21.85M
Operating Income Q2 2024 · Jun 30, 2023 −$22.25M
Revenue Q2 2024 · Jun 30, 2023 $19.31M